Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;21(10):1351-1352.
doi: 10.1016/S1473-3099(21)00482-5. Epub 2021 Aug 13.

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants

Luke B Snell  1 , Penelope R Cliff  2 , Themoula Charalampous  3 , Adela Alcolea-Medina  2 , Saidat A R T Ebie  2 , Jasveen K Sehmi  2 , Flavia Flaviani  3 , Rahul Batra  3 , Sam T Douthwaite  3 , Jonathan D Edgeworth  3 , Gaia Nebbia  3
Affiliations

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants

Luke B Snell et al. Lancet Infect Dis. 2021 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests. This work was funded by the National Institute for Health Research Biomedical Research Centre programme of infection and immunity (RJ112/N027) based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London, Guy's and St Thomas' NHS Foundation Trust, and The Guy's and St Thomas' Charity.

References

    1. European Centre for Disease Prevention and Control SARS-CoV-2 variants of concern as of 15 July 2021. https://www.ecdc.europa.eu/en/covid-19/variants-concern
    1. Jangra S, Ye C, Rathnasinghe R, et al. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021;2:e283–e284. - PMC - PubMed
    1. Greaney AJ, Starr TN, Barnes CO, et al. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat Commun. 2021;12:1–14. - PMC - PubMed
    1. Hu J, Peng P, Wang K, et al. Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies. Cell Mol Immunol. 2021;18:1061–1063. - PMC - PubMed
    1. Madhi SA, Baillie V, Cutland CL, et al. Efficacy of the ChAdOx1 nCoV-19 COVID-19 vaccine against the B.1.351 variant. N Engl J Med. 2021;384:1885–1898. - PMC - PubMed

Publication types

Substances